Connect with us
In ten years since its inception, Moderna has transformed from a research-stage company advancing programs in the messenger RNA (mRNA) field to a company with a...
Moderna closed 2021 with a profit of $12.2 billion, compared to a loss of $747 million recorded in 2020. Moderna's total revenue in 2021 was $18.471...
In the fourth quarter of 2021, Moderna achieved a profit of $4.87 billion compared with a loss of $272 million in 2020. Total revenue increased from...
The Spanish pharmaceutical company Rovi achieved a net profit of $60.3 million (€51 million) from January to June, compared to $35 million (€29.6 million) a year...
Rovi will start producing Moderna's COVID-19 vaccine in Andalusia. This investment consists of the installation of a new line to support the production phases of the...
The total shareholder return in 2020 was 19.3% in CHF and 18.1% in EUR, slightly below the performance of the underlying portfolio. In addition to Mersana...
The US company Moderna with its mRNA-based COVID-19 vaccine is currently the best-known example of how biotech companies are making progress for society. In addition to...
A recent study conducted in France by Stratégies and Leyton shows that 88% of the French people are happy that a vaccine against COVID-19 was found....
The company operates under the name of Moderna Biotech Spain and its corporate purpose is the "development, manufacture and distribution of drugs, vaccines and medicines based...